These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33078583)

  • 21. Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.
    Bessler WK; Hudson FZ; Zhang H; Harris V; Wang Y; Mund JA; Downing B; Ingram DA; Case J; Fulton DJ; Stansfield BK
    Free Radic Biol Med; 2016 Aug; 97():212-222. PubMed ID: 27266634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.
    Kobus K; Hartl D; Ott CE; Osswald M; Huebner A; von der Hagen M; Emmerich D; Kühnisch J; Morreau H; Hes FJ; Mautner VF; Harder A; Tinschert S; Mundlos S; Kolanczyk M
    PLoS One; 2015; 10(3):e0119030. PubMed ID: 25775093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nf1 has an essential role in endothelial cells.
    Gitler AD; Zhu Y; Ismat FA; Lu MM; Yamauchi Y; Parada LF; Epstein JA
    Nat Genet; 2003 Jan; 33(1):75-9. PubMed ID: 12469121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring functional neurofibromin by protein transduction.
    Mellert K; Lechner S; Lüdeke M; Lamla M; Möller P; Kemkemer R; Scheffzek K; Kaufmann D
    Sci Rep; 2018 Apr; 8(1):6171. PubMed ID: 29670214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).
    O'Donohue AK; Li XC; Lee LR; Vasiljevski ER; Little DG; Munns CF; Schindeler A
    PLoS One; 2024; 19(6):e0304778. PubMed ID: 38913608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
    Abramowicz A; Gos M
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.
    Stansfield BK; Bessler WK; Mali R; Mund JA; Downing BD; Kapur R; Ingram DA
    Am J Pathol; 2014 Jan; 184(1):79-85. PubMed ID: 24211110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice.
    Gutmann DH; Winkeler E; Kabbarah O; Hedrick N; Dudley S; Goodfellow PJ; Liskay RM
    Oncogene; 2003 Jul; 22(29):4581-5. PubMed ID: 12881715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
    Kamiya N; Yamaguchi R; Aruwajoye O; Kim AJ; Kuroyanagi G; Phipps M; Adapala NS; Feng JQ; Kim HK
    J Bone Miner Res; 2017 Aug; 32(8):1716-1726. PubMed ID: 28425622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
    El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
    J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.
    Hakimi MA; Speicher DW; Shiekhattar R
    J Biol Chem; 2002 Oct; 277(40):36909-12. PubMed ID: 12191989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
    Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
    J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
    Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
    J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
    McGillicuddy LT; Fromm JA; Hollstein PE; Kubek S; Beroukhim R; De Raedt T; Johnson BW; Williams SM; Nghiemphu P; Liau LM; Cloughesy TF; Mischel PS; Parret A; Seiler J; Moldenhauer G; Scheffzek K; Stemmer-Rachamimov AO; Sawyers CL; Brennan C; Messiaen L; Mellinghoff IK; Cichowski K
    Cancer Cell; 2009 Jul; 16(1):44-54. PubMed ID: 19573811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
    Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
    J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
    Abramowicz A; Gos M
    Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.